Live from the NIH registry
Studies recruiting near New Orleans right now
Top 25 of 564 recruiting studies, sorted by proximity — each links to its official registry page
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
LSU Health Sciences Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Tulane University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Westat
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: SWOG Cancer Research Network
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Tulane University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Jaeb Center for Health Research
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
Ochsner Health — Jefferson, Louisiana (15.2 mi)
· Sponsor: Astellas Pharma Inc
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi)
· Sponsor: Eli Lilly and Company
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Tulane Cancer Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: Guardant Health, Inc.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research - LCMC Health Urgent Care - Lakeview — New Orleans, Louisiana (11.8 mi)
· Sponsor: Crystalys Therapeutics
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Omega Clinical Research — Metairie, Louisiana (14.6 mi)
· Sponsor: Novartis Pharmaceuticals
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Papillomavirus Vaccines, Human Immunodeficiency Virus
Phase 4
Interventional 250 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Louisiana State University Health Sciences Center in New Orleans
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
Emotional Distress, Prosocial Behavior
N/A
Interventional 800 participants sought
Coalition for Compassionate Schools — New Orleans, Louisiana (11.8 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Tulane School of Medicine — New Orleans, Louisiana (11.8 mi)
· Sponsor: Duke University
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Crescent City Headache & Neurology Center — Chalmette, Louisiana (9.0 mi)
· Sponsor: Kallyope Inc.
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Tulane University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Duke University
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Ochsner Health, New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Calliditas Therapeutics AB
Spinal Cord Injury Registry - North American Clinical Trials Network
Spinal Cord Injury
N/A
Observational 1,500 participants sought
Louisiana State University Medical Sciences Center in New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Robert G. Grossman, MD
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — New Orleans, Louisiana (11.8 mi)
· Sponsor: AstraZeneca
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Obesity
N/A
Interventional 522 participants sought
NOELA Community Health Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: Tulane University
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Pontchartrain Cancer Center — Covington, Louisiana (29.9 mi)
· Sponsor: Shanghai Henlius Biotech
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — New Orleans, Louisiana (11.8 mi)
· Sponsor: AstraZeneca